Alzprotect

Developing Tau-protein targeted small molecule drugs for neurodegenerative diseases

placeLoos, Hauts De France, France calendar_todayFounded 2007 groups10 employees language alzprotect.com

Innovation

7 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 219 times.

YearFilings
20143
20151
20162
20172
20182
20191
20201
20211
20223
20234
20244
20254

Investor mix

5 investors on record; lead investors include Xerys.

Investor typeCountShare
Venture capital480%
Private equity120%
Coming soon